Article
New mindset suggested for prescribing beta-blockers
Since the release of the topical beta-blocker timolol maleate (Timoptic, Merck) some 2 decades ago, glaucoma patients have been the beneficiaries of a cascade of new IOP-lowering pharmaceuticals.
Related Videos
Related Content
